The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved teprizumab (Tzield, Aventis Pharma Limited) as the UK's first immunotherapy for type 1 diabetes (T1D). The drug is approved for …
Copyright MatchingDonors.com©️ 2025 All rights reserved.